Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 22695302)

1.

Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R.

AIDS. 2012 Nov 13;26(17):2121-33. doi: 10.1097/QAD.0b013e3283565dd1. Review.

2.

Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.

Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS.

Int J Tuberc Lung Dis. 2012 Jan;16(1):90-7. doi: 10.5588/ijtld.11.0153.

3.

The HIV-associated tuberculosis epidemic--when will we act?

Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM.

Lancet. 2010 May 29;375(9729):1906-19. doi: 10.1016/S0140-6736(10)60409-6. Epub 2010 May 18. Review.

PMID:
20488516
4.

Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.

Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, Kestens L, Colebunders R.

Clin Dev Immunol. 2011;2011:758350. doi: 10.1155/2011/758350. Epub 2010 Dec 8.

5.

Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.

Gray DM, Zar H, Cotton M.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006418. doi: 10.1002/14651858.CD006418.pub2. Review.

6.

Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.

Oladimeji O, Isaakidis P, Obasanya OJ, Eltayeb O, Khogali M, Van den Bergh R, Kumar AM, Hinderaker SG, Abdurrahman ST, Lawson L, Cuevas LE.

PLoS One. 2014 Apr 10;9(4):e94393. doi: 10.1371/journal.pone.0094393. eCollection 2014.

7.

Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.

Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD.

PLoS One. 2013;8(2):e55824. doi: 10.1371/journal.pone.0055824. Epub 2013 Feb 13.

8.

Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.

Lawn SD, Harries AD, Wood R.

Curr Opin HIV AIDS. 2010 Jan;5(1):18-26. doi: 10.1097/COH.0b013e328333850f. Review.

9.

The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting.

Houben RM, Glynn JR, Mboma S, Mzemba T, Mwaungulu NJ, Mwaungulu L, Mwenibabu M, Mpunga J, French N, Crampin AC.

AIDS. 2012 Nov 13;26(17):2233-9. doi: 10.1097/QAD.0b013e32835958ed.

PMID:
22951633
10.
11.

Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.

Harries AD, Zachariah R, Lawn SD.

Int J Tuberc Lung Dis. 2009 Jan;13(1):6-16. Review.

PMID:
19105873
14.
15.

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R.

PLoS Med. 2011 Jul;8(7):e1001067. doi: 10.1371/journal.pmed.1001067. Epub 2011 Jul 26.

16.

Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.

Hermans SM, van Leth F, Manabe YC, Hoepelman AI, Lange JM, Kambugu A.

HIV Med. 2012 Jul;13(6):337-44. doi: 10.1111/j.1468-1293.2011.00980.x. Epub 2012 Feb 2.

PMID:
22296211
17.

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Lawn SD, Myer L, Edwards D, Bekker LG, Wood R.

AIDS. 2009 Aug 24;23(13):1717-25. doi: 10.1097/QAD.0b013e32832d3b6d.

18.

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.

Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, Djomand G, Ackah A, Domoua K, Kadio A, Yapi A, Combe P, Tossou O, Roels TH, Lackritz EM, Coulibaly D, De Cock KM, Coulibaly IM, Greenberg AE.

Lancet. 1999 May 1;353(9163):1469-75. Erratum in: Lancet 1999 Jun 12;353(9169):2078.

PMID:
10232312
19.

Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.

Mwaungulu FB, Floyd S, Crampin AC, Kasimba S, Malema S, Kanyongoloka H, Harries AD, Glynn JR, Fine PE.

Bull World Health Organ. 2004 May;82(5):354-63.

20.

HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.

Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, Sirinak C, Nateniyom S, Burapat C, Kittikraisak W, Monkongdee P, Varma JK.

Int J Infect Dis. 2009 Nov;13(6):722-9. doi: 10.1016/j.ijid.2008.11.013. Epub 2009 Feb 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk